AVBCC 2020 Summit

Utilization management tools and prior authorization are associated with delays in care for patients and high costs for physicians. In this session, panelists discuss the impact on cancer care, with an eye toward providing appropriate care while minimizing administrative burden. Read More ›

With multiple stakeholders playing a key role in value-based contracting, the pharmaceutical industry faces many obstacles. In this session, experts discuss these obstacles and the strategies for overcoming them. Read More ›

340B is a discount program for low-income areas that increases resources and allows for patient expansion. In this session, panelists discuss the accuracy of pricing, the current state of the program, and future developments. Read More ›

In this session, industry leaders discuss defining clinical utility for genomic testing and make recommendations to ensure appropriate implementation in cancer care. Read More ›

Technology can enhance the patient engagement experience, creating a willingness among patients to receive advice and counseling virtually. In this session, experts discuss the challenges of engaging patients and the future of technology in the healthcare system as it relates to cancer care. Read More ›

No one truly knows what it is like to navigate cancer until they are diagnosed with the disease. In this session, survivors shared their stories and messages of hope as we prepare for Thanksgiving. Read More ›

Depending on the stakeholder’s point of view, value-based contracting can have many definitions and meanings. In this session, experts from across the healthcare continuum explore what is working, what has failed, and what lessons have been learned regarding value-based contracting. Read More ›

Designing and implementing value-based contracts is a challenge to stakeholders across the cancer care ecosystem. In this discussion, panelists analyze the future of these contracts and precision medicine. Read More ›

During the COVID-19 pandemic, telehealth has been considered a silver lining in that it has allowed increased access to care. In this session, experts discuss the early challenges of telehealth and how it can improve the future of cancer care. Read More ›